Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Mr. David Frank HoffmeisterIndependent Director | 15,00k | 370,35k | Derivative Exercise and Retained Stock | 24,69 | 82,99k | 22,06% |
| 2026-05-14 | Dr. Gilbert H. KlimanIndependent Director | -5,00k | 580,35k | Derivative Exercise and Sale | 24,69 - 140,76 | 32,80k | - |
| 2026-05-11 | Dr. Gilbert H. KlimanIndependent Director | -5,00k | 551,55k | Derivative Exercise and Sale | 24,69 - 135,00 | 32,80k | - |
| 2026-04-30 | Mr. Alex R. ThurmanSenior VP & CFO | -10,00k | 1,01M | Derivative Exercise and Sale | 38,68 - 140,00 | 38,45k | - |
| 2026-05-01 | Mr. Joseph E. GilliamPresident & COO | -19,57k | 2,81M | Verkauf | 143,54 | 29,49k | -39,89% |
| 2026-05-01 | Dr. Leana S. WenIndependent Director | -1,70k | 243,70k | Verkauf | 143,35 | 17,01k | -9,09% |
| 2026-04-10 | Dr. Tomas NavratilChief Development Officer | -2,09k | 246,18k | Automatic Disposition | 116,72 - 120,23 | 50,58k | -3,97% |
| 2026-04-02 | Dr. Tomas NavratilChief Development Officer | -2,98k | 326,28k | Sale to Issuer | 109,60 | 52,67k | -5,35% |
| 2026-04-02 | Mr. Alex R. ThurmanSenior VP & CFO | -1,59k | 174,15k | Sale to Issuer | 109,60 | 38,45k | -3,97% |
| 2026-04-02 | Mr. Joseph E. GilliamPresident & COO | -3,17k | 347,32k | Sale to Issuer | 109,60 | 49,07k | -6,07% |
| 2026-04-02 | Mr. Thomas William BurnsChairman & CEO | -9,94k | 1,09M | Sale to Issuer | 109,60 | 567,04k | -1,72% |
| 2026-04-01 | Mr. Thomas William BurnsChairman & CEO | -180,31k | 0,00 | Other Disposition | - | 567,04k | -24,13% |
| 2026-03-31 | Dr. Tomas NavratilChief Development Officer | -5,80k | 635,46k | Sale to Issuer | 109,60 | 49,65k | -10,46% |
| 2026-03-25 | Mr. Alex R. ThurmanSenior VP & CFO | -2,51k | 267,32k | Automatic Disposition | 106,46 | 36,74k | -6,40% |
| 2026-03-24 | Mr. Thomas William BurnsChairman & CEO | -2,74k | 288,75k | Sale to Issuer | 105,23 | 1,70M | -0,16% |
| 2026-03-23 | Dr. Tomas NavratilChief Development Officer | -5,17k | 548,69k | Sale to Issuer | 105,23 - 106,84 | 43,75k | -10,58% |
| 2026-03-24 | Mr. Alex R. ThurmanSenior VP & CFO | -1,52k | 160,07k | Automatic Disposition | 105,24 | 39,25k | -3,73% |
| 2026-03-23 | Mr. Alex R. ThurmanSenior VP & CFO | -3,25k | 343,98k | Sale to Issuer | 105,23 - 106,84 | 39,25k | -7,65% |
| 2026-03-23 | Mr. Joseph E. GilliamPresident & COO | -15,12k | 1,60M | Sale to Issuer | 105,23 - 106,84 | 46,41k | -24,57% |
| 2026-03-17 | Mr. Alex R. ThurmanSenior VP & CFO | -625,00 | 61,97k | Automatic Disposition | 99,15 | 36,74k | -1,67% |
| 2026-03-16 | Mr. Alex R. ThurmanSenior VP & CFO | -614,00 | 60,75k | Sale to Issuer | 98,94 | 36,74k | -1,64% |
| 2026-03-16 | Mr. Joseph E. GilliamPresident & COO | -1,19k | 117,64k | Sale to Issuer | 98,94 | 33,67k | -3,41% |
| 2026-03-16 | Mr. Thomas William BurnsChairman & CEO | -2,80k | 277,13k | Sale to Issuer | 98,94 | 1,70M | -0,16% |
| 2026-03-16 | Dr. Tomas NavratilChief Development Officer | -1,03k | 101,08k | Automatic Disposition | 97,33 - 99,05 | 37,94k | -2,65% |
| 2026-03-16 | Dr. Tomas NavratilChief Development Officer | -958,00 | 94,78k | Sale to Issuer | 98,94 | 37,94k | -2,46% |
| 2026-03-13 | Mr. Joseph E. GilliamPresident & COO | -2,46k | 238,86k | Sale to Issuer | 97,02 | 32,72k | -7,00% |
| 2026-03-13 | Dr. Tomas NavratilChief Development Officer | -1,07k | 104,20k | Sale to Issuer | 97,02 | 37,16k | -2,81% |
| 2026-03-13 | Mr. Thomas William BurnsChairman & CEO | -5,21k | 505,67k | Sale to Issuer | 97,02 | 1,69M | -0,31% |
| 2026-03-05 | Dr. Tomas NavratilChief Development Officer | -361,00 | 40,47k | Sale to Issuer | 112,10 | 35,13k | -1,02% |
| 2026-03-05 | Mr. Thomas William BurnsChairman & CEO | -1,10k | 123,09k | Sale to Issuer | 112,10 | 1,69M | -0,06% |
| 2026-02-24 | Mr. Thomas William BurnsChairman & CEO | -4,06k | 483,71k | Sale to Issuer | 119,17 | 1,69M | -0,24% |
| 2026-02-24 | Dr. Tomas NavratilChief Development Officer | -396,00 | 47,19k | Sale to Issuer | 119,17 | 34,47k | -1,14% |
| 2026-02-24 | Mr. Joseph E. GilliamPresident & COO | -1,06k | 125,96k | Sale to Issuer | 119,17 | 30,65k | -3,33% |
| 2026-02-19 | Ms. Aimee S. WeisnerIndependent Director | -15,00k | 1,39M | Derivative Exercise and Sale | 24,69 - 118,56 | 47,58k | - |
| 2026-02-19 | Ms. Aimee S. WeisnerIndependent Director | -980,00 | 0,00 | Other Disposition | - | 47,58k | -2,02% |
| 2026-02-09 | Mr. Thomas William BurnsChairman & CEO | 166,00k | 5,13M | Derivative Exercise and Retained Stock | 30,92 | 1,69M | 10,93% |
| 2026-02-06 | Mr. Thomas William BurnsChairman & CEO | -67,35k | 0,00 | Other Disposition | - | 1,69M | -3,84% |
| 2026-01-22 | Mr. Marc A. StapleyIndependent Director | -15,00k | 1,55M | Derivative Exercise and Sale | 24,69 - 129,78 | 34,61k | - |
| 2026-01-22 | Mr. Joseph E. GilliamPresident & COO | -10,50k | 761,10k | Derivative Exercise and Sale | 55,18 - 129,28 | 29,76k | - |
| 2026-01-21 | Mr. Joseph E. GilliamPresident & COO | -4,50k | 312,75k | Derivative Exercise and Sale | 55,18 - 124,65 | 29,76k | - |
| 2026-01-08 | Mr. Thomas William BurnsChairman & CEO | -275,00k | 27,09M | Derivative Exercise and Sale | 16,49 - 115,00 | 1,52M | - |
| 2025-12-30 | Mr. Thomas William BurnsChairman & CEO | -1,10k | 125,44k | Sale to Issuer | 114,24 | 1,52M | -0,07% |
| 2025-12-30 | Dr. Tomas NavratilChief Development Officer | -510,00 | 58,26k | Sale to Issuer | 114,24 | 33,89k | -1,48% |
| 2025-12-09 | Dr. Gilbert H. KlimanIndependent Director | -5,00k | 412,90k | Derivative Exercise and Sale | 24,69 - 107,27 | 32,34k | - |
| 2025-11-25 | Mr. Alex R. ThurmanSenior VP & CFO | -315,00 | 33,08k | Automatic Disposition | 105,00 | 36,74k | -0,85% |
| 2025-11-18 | Mr. Joseph E. GilliamPresident & COO | -19,34k | 1,74M | Verkauf | 90,00 | 29,76k | -39,39% |
| 2025-09-23 | Mr. Joseph E. GilliamPresident & COO | -1,06k | 89,43k | Sale to Issuer | 84,69 | 49,10k | -2,11% |
| 2025-09-23 | Mr. Thomas William BurnsChairman & CEO | -4,06k | 343,76k | Sale to Issuer | 84,69 | 1,52M | -0,27% |
| 2025-09-22 | Dr. Tomas NavratilChief Development Officer | -517,00 | 43,54k | Automatic Disposition | 82,79 - 84,70 | 33,37k | -1,53% |
| 2025-09-23 | Dr. Tomas NavratilChief Development Officer | -483,00 | 40,91k | Sale to Issuer | 84,69 | 33,37k | -1,43% |
| 2025-09-19 | Dr. Tomas NavratilChief Development Officer | -510,00 | 42,57k | Sale to Issuer | 83,47 | 33,40k | -1,50% |
| 2025-09-19 | Mr. Thomas William BurnsChairman & CEO | -1,10k | 91,65k | Sale to Issuer | 83,47 | 1,51M | -0,07% |
| 2025-09-11 | Dr. Tomas NavratilChief Development Officer | -5,14k | 453,62k | Automatic Disposition | 87,98 - 88,61 | 32,88k | -13,52% |
| 2025-06-11 | Mr. David Frank HoffmeisterIndependent Director | 25,00k | 800,00k | Derivative Exercise and Retained Stock | 32,00 | 67,43k | 58,92% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
